DRESS syndrome primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D., Serge Korjian M.D.
Overview
Overview
There are no established measures for the primary prevention of DRESS syndrome. Primary prevention measures may include slow dose escalation of drugs (e.g. anticonvulsants), genetic counseling, and in vitro impaired detoxification testing.
Primary Prevention
Primary Prevention
There are no established measures for the primary prevention of DRESS syndrome. Primary prevention measures may include the following:[1]
References
References
- ↑ Tas S, Simonart T (2003). “Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update”. Dermatology. 206 (4): 353–6. doi:69956 Check
|doi=value (help). PMID 12771485. - ↑ Fitton A, Goa KL (1995). “Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy”. Drugs. 50 (4): 691–713. PMID 8536554.
- ↑ 3.0 3.1 Sullivan JR, Shear NH (2000). “What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions?”. Br J Dermatol. 142 (2): 205–7. PMID 10730749.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
